MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations (Q42731321)
Jump to navigation
Jump to search
scientific article published on October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations |
scientific article published on October 2011 |
Statements
1 reference
MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations (English)
1 reference
Junko Tanizaki
1 reference
Isamu Okamoto
1 reference
Kunio Okamoto
1 reference
Ken Takezawa
1 reference
Kiyoko Kuwata
1 reference
Haruka Yamaguchi
1 reference
Kazuhiko Nakagawa
1 reference
1 October 2011
1 reference
1 reference
Identifiers
1 reference